Summary of Purpose
The project is a multi-centric initiative to study the safety, feasibility and efficacy of using intravenous autologous bone marrow mononuclear cells (BMMC) in patients with acute ischaemic stroke. This phase of study is visualized as phase 2 study and will aim to determine the dose response gradient of stem cell therapy and to explore if there is favorable risk to benefit ratio for stem cell therapy in patients with acute ischaemic stroke....Read More →
The following dates are available for this trial. Trial information last updated on 21 December 2010.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi
Randomized, parallel group, active controlled trial
Professor of Neurology, Room No- 704, C.N Centre, Department of Neurology, All India Institute of Medical Sciences,New Delhi, INDIA Tel:01126588979 Fax:email@example.com